ArticleResearch square2023

Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.

Carlyn Rose Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.